Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-1.93 Insider Own13.65% Shs Outstand47.26M Perf Week13.86%
Market Cap199.23M Forward P/E- EPS next Y-1.65 Insider Trans-0.28% Shs Float41.06M Perf Month-37.83%
Income-85.08M PEG- EPS next Q-0.41 Inst Own62.76% Short Float6.94% Perf Quarter-56.40%
Sales2.71M P/S73.52 EPS this Y22.38% Inst Trans-3.73% Short Ratio6.32 Perf Half Y-58.47%
Book/sh2.71 P/B1.55 EPS next Y-3.66% ROA-52.52% Short Interest2.85M Perf Year53.48%
Cash/sh2.41 P/C1.74 EPS next 5Y- ROE-59.40% 52W Range1.33 - 11.76 Perf YTD-41.23%
Dividend Est.- P/FCF- EPS past 5Y-63.20% ROI-64.45% 52W High-64.37% Beta1.75
Dividend TTM- Quick Ratio9.15 Sales past 5Y40.60% Gross Margin-50.72% 52W Low215.01% ATR (14)0.44
Dividend Ex-Date- Current Ratio9.15 EPS Y/Y TTM16.70% Oper. Margin-3327.44% RSI (14)37.94 Volatility9.58% 10.84%
Employees75 Debt/Eq0.03 Sales Y/Y TTM282.93% Profit Margin-3133.63% Recom1.33 Target Price11.00
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q25.07% Payout- Rel Volume0.81 Prev Close4.05
Sales Surprise265.93% EPS Surprise17.39% Sales Q/Q1856.14% EarningsMay 02 BMO Avg Volume451.48K Price4.19
SMA20-3.35% SMA50-38.90% SMA200-34.54% Trades Volume367,769 Change3.46%
Date Action Analyst Rating Change Price Target Change
Jun-17-24Downgrade BTIG Research Buy → Neutral
Aug-31-22Initiated BTIG Research Buy $12
Jun-01-22Initiated Citigroup Buy $13
May-02-22Initiated H.C. Wainwright Buy $28
Apr-14-21Initiated Berenberg Buy $47
Jan-11-21Initiated Evercore ISI Outperform
Nov-03-20Initiated Needham Buy $34
Nov-03-20Initiated Cowen Outperform
Nov-03-20Initiated Citigroup Buy $36
Jul-01-24 06:00AM
Jun-18-24 06:25PM
Jun-14-24 01:28PM
07:30AM Loading…
Jun-10-24 07:30AM
Jun-06-24 07:30AM
May-21-24 09:35AM
May-14-24 04:15PM
May-07-24 12:00PM
May-04-24 05:31AM
May-02-24 09:58PM
04:05PM Loading…
Apr-09-24 04:05PM
Apr-01-24 07:00AM
Mar-04-24 07:00AM
Feb-29-24 04:05PM
Feb-26-24 07:00AM
Feb-14-24 05:06AM
Feb-13-24 06:00AM
Jan-08-24 07:00AM
Jan-04-24 04:05PM
Dec-21-23 08:00AM
Dec-13-23 10:45AM
Dec-05-23 04:15PM
Nov-14-23 09:00AM
Nov-13-23 08:52AM
11:54PM Loading…
Nov-09-23 11:54PM
Nov-06-23 09:28AM
Nov-02-23 09:01AM
Oct-24-23 12:30PM
Aug-10-23 05:15PM
Jul-06-23 10:14AM
May-25-23 05:15PM
May-09-23 05:15PM
Apr-03-23 07:00AM
Mar-21-23 11:50AM
Mar-16-23 08:31AM
Mar-01-23 07:00AM
Feb-27-23 10:46PM
Feb-23-23 04:30PM
Feb-16-23 07:00AM
Feb-09-23 06:01AM
Jan-27-23 08:34AM
Jan-09-23 07:00AM
Dec-13-22 06:51AM
Dec-01-22 09:55AM
Nov-11-22 05:51AM
Nov-08-22 04:30PM
Nov-07-22 08:00AM
Nov-04-22 11:55AM
Nov-03-22 08:30AM
Nov-01-22 04:30PM
Oct-12-22 10:04AM
Oct-05-22 04:30PM
Sep-01-22 04:15PM
Aug-20-22 08:41AM
Aug-11-22 07:00AM
Jul-06-22 07:20AM
May-28-22 08:05AM
May-13-22 08:50AM
May-12-22 07:00AM
May-06-22 09:00AM
May-05-22 09:14AM
Apr-08-22 04:55PM
Apr-05-22 05:00PM
Mar-21-22 12:00PM
Mar-15-22 07:00AM
Mar-09-22 08:21AM
Mar-02-22 08:39AM
Feb-09-22 05:00PM
Feb-02-22 01:38PM
Jan-27-22 09:21AM
Jan-05-22 08:30AM
Dec-13-21 01:57PM
Dec-03-21 07:59PM
Dec-02-21 03:40PM
Dec-01-21 10:45PM
Nov-29-21 10:30AM
Nov-28-21 07:58PM
Nov-26-21 12:39PM
Nov-25-21 11:23PM
Nov-23-21 05:44PM
Nov-22-21 01:00PM
Nov-21-21 11:20PM
Nov-18-21 04:01PM
Nov-15-21 11:32PM
Nov-11-21 05:55PM
Nov-10-21 12:30PM
Nov-09-21 01:19PM
Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brous TylerDirectorJun 28 '24Buy3.903,00011,700238,088Jul 01 06:30 AM
Brous TylerDirectorJun 27 '24Buy3.895,41621,068235,088Jul 01 06:30 AM
Schreiber TaylorChief Executive OfficerJun 26 '24Buy3.4714,40050,01134,502Jun 26 04:15 PM
Schreiber TaylorChief Executive OfficerJun 04 '24Option Exercise3.573,05010,88820,102Jun 05 06:05 AM
Stout StephenSee RemarksMar 06 '24Option Exercise3.5411,10939,38085,791Mar 08 05:40 PM
Stout StephenSee RemarksMar 06 '24Sale10.5316,004168,52274,437Mar 08 05:40 PM
Neill Andrew RChief Financial OfficerJan 10 '24Sale10.0025,000250,000173,446Jan 16 04:35 PM